Clinical Trials Analysis
🌏 NMPAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 21 articles
Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035
5 min
Dr. Yuki TanakaClinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook
5 min
Dr. Yuki TanakaNektar Therapeutics pipeline update: REZPEG clinical programs and regulatory context
atopic dermatitis · 5 min
Dr. Yuki TanakaHengrui Pharma and Kailera Therapeutics Present Ribupatide Data at ADA 2026
GLP-1 · 5 min
Dr. Yuki TanakaASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds
oncology · 7 min
Dr. Yuki TanakaPoly Medicure appoints Indranil Mukherjee as CEO, APAC & India: Strategic implications for pharma BD teams
4 min
Dr. Yuki TanakaCell Therapy Packaging Market Size & Share Report, 2033: Key Trends and Forecasts
cell therapy · 4 min
Dr. Yuki TanakaOrion Pharma's ODM-212 Shows Favorable Safety in Phase 1/2 TEADES Trial for Advanced Solid Tumours
advanced solid tumours · 4 min
Dr. Yuki TanakaThe Pharma Choke Point: A Strategic Risk for U.S. Pharmaceutical Supply Chains
5 min
Dr. Yuki TanakaEcosystem Over Geography: Life Sciences Location Strategy in APAC
EMA · 5 min
Dr. Yuki TanakaHelus Pharma to Participate in the Jefferies Global Healthcare Conference: Strategic Implications for Analysts and BD Teams
4 min
Dr. Yuki TanakaAcclinate and HCN Global Forge Strategic Partnership to Enhance Clinical Research Diversity
6 min
Dr. Yuki Tanaka